A Severe Asthma Disease Signature from Gene Expression Profiling of Peripheral Blood from U-BIOPRED Cohorts.

导出 LinkOut

翻译打印收藏纠错

第一作者： Jeannette,Bigler

第一单位： 1 Amgen Inc., Seattle, Washington.

作者： Jeannette,Bigler ^[1] ; Michael,Boedigheimer ^[2] ; James P R,Schofield ^[3] ; Paul J,Skipp ^[3] ; Julie,Corfield ^[4] ; Anthony,Rowe ^[5] ; Ana R,Sousa ^[6] ; Martin,Timour ^[1] ; Lori,Twehues ^[2] ; Xuguang,Hu ^[7] ; Graham,Roberts ^[8] ; Andrew A,Welcher ^[2] ; Wen,Yu ^[1] ; Diane,Lefaudeux ^[9] ; Bertrand De,Meulder ^[9] ; Charles,Auffray ^[9] ; Kian F,Chung ^[10] ; Ian M,Adcock ^[10] ; Peter J,Sterk ^[11] ; Ratko,Djukanović ^[8] ; U-BIOPRED Study Group ‖

作者单位： 1 Amgen Inc., Seattle, Washington. ^[1] 2 Amgen Inc., Thousand Oaks, California. ^[2] 3 Centre for Biological Sciences, Southampton University, Southampton, United Kingdom. ^[3] 4 AstraZeneca R&D, Molndal, Sweden.;5 Areteva R&D, Nottingham, United Kingdom. ^[4] 6 Janssen Research and Development, High Wycombe, United Kingdom. ^[5] 7 Respiratory Therapeutic Unit, GSK, Stockley Park, United Kingdom. ^[6] 8 Amgen Inc., South San Francisco, California. ^[7] 9 Respiratory Biomedical Research Unit, Faculty of Medicine, University Hospital Southampton, Southampton, United Kingdom. ^[8] 10 European Institute for Systems Biology and Medicine, Centre National de la Recherche Scientifique, Lyon, France. ^[9] 11 National Heart & Lung Institute, Imperial College & Biomedical Research Unit, Royal Brompton & Harefield NHS Trust, London, United Kingdom; and. ^[10] 12 Department of Respiratory Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, the Netherlands. ^[11]

关键词 biomarker immune cell microarray